Sultiame once per day in obstructive sleep apnoea (FLOW): a multicentre, randomised, double-blind, placebo-controlled, dose-finding, phase 2 trial
Winfried Randerath(University of Cologne), Samuel Genzor, Zbyšek Pavelek, Jan Hedner(Sahlgrenska University Hospital), J. Bravo Albares(Hospital Quirón Teknon), Dries Testelmans(KU Leuven), Kaj Stenlöf(Sahlgrenska University Hospital), Benny Mwenge, C. Deckert, Ainhoa Álvarez Ruiz De Larrínaga, Ingo Fietze(Humboldt-Universität zu Berlin), Maxime Patout(Guy's and St Thomas' NHS Foundation Trust), Ludger Grote(Sahlgrenska University Hospital), Andreas Völp(Sahlgrenska University Hospital), Corinna Hansen(Desitin Arzneimittel (Germany)), Jean‐Benoît Martinot, Heike Beneš(Siesta Group (Austria)), Henning Candler, Frédéric Gagnadoux(Inserm), Pierre Philip, Katrin Kuhn(Desitin Arzneimittel (Germany)), F Martínez-Orozco(Hospital Clínico San Carlos), Francisco Javier Albares Tendero, Christian Viniol, Frank Kaessner, Farhad Baharloo
Cited by 15
Related Papers
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Cohort Profile: The Study of Health in Pomerania
|International Journal of Epidemiology|2010|1k
Effect of Nasal Continuous Positive Airway Pressure Treatment on Blood Pressure in Patients With Obstructive Sleep Apnea
|Circulation|2003|929
Increased Incidence of Cardiovascular Disease in Middle-aged Men with Obstructive Sleep Apnea: A 7-Year Follow-up
|American Journal of Respiratory and Critical Care Medicine|2002|787